April 23, 2025
TOPLINE: Apremilast treatment for 1 year significantly reduced abdominal fat and maintained lean mass in patients with psoriatic arthritis (PsA), alongside notable improvements in disease activity. […]
April 21, 2025
TOPLINE: Patients with obesity and early rheumatoid arthritis (RA) had an increased risk for remission failure after 6 months of starting methotrexate treatment, regardless of the […]
April 21, 2025
DENVER — The greater the social disadvantage is for children with juvenile idiopathic arthritis (JIA), the higher their odds are of having active disease, according to […]
April 21, 2025
TOPLINE: Higher testosterone levels were significantly associated with a lower prevalence of radiographic knee osteoarthritis (RKOA) and a lower risk for chronic knee pain (CKP) in […]
April 18, 2025
A multidisciplinary team has released new evidence-based recommendations for the management of familial Mediterranean fever (FMF). Jointly endorsed by the European Alliance of Associations for Rheumatology […]
April 18, 2025
TOPLINE: Avacopan treatment for antineutrophil cytoplasmic antibody–associated vasculitis demonstrated lower rates of adverse events, serious adverse events, white blood cell (WBC) count reductions, and infections than […]
April 17, 2025
TOPLINE: In patients with psoriasis or ankylosing spondylitis, the use of interleukin (IL)-17A inhibitors, particularly secukinumab, was associated with an increased risk for inflammatory bowel disease […]
April 15, 2025
TOPLINE: Janus kinase (JAK) inhibitors led to improvement of uveitis in approximately half of pediatric patients previously treated with disease-modifying antirheumatic drugs (DMARDs) in a case […]
April 14, 2025
DENVER — Neuropsychiatric lupus is “arguably the least understood manifestation” of systemic lupus erythematosus (SLE) in children, with patients facing substantial barriers and experiencing highly variable […]